Effect of intranasal insulin administering on patients with loss of smell

Effect of intranasal insulin administering on returning of the smell in patients with hyposmia.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2017061712782N15

Enrollment

Registered

2017-07-09

Start date

2014-12-31

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyposmia. Disturbances of smell and taste

Interventions

Intervention 1: Intervention group: patients under treated with intranasal insulin. Intervention 2: Control group: patients under treated with normal saline intranasal.

Treatment - Drugs

Intervention group: patients under treated with intranasal insulin

Control group: patients under treated with normal saline intranasal

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: hyposmic patients with CCCRC scores 2 to 5.75; patients not are under general anesthesia in this treatment; don't use corticosteroid in treatment duration; patients aren't hypoglycemia or diabetes; patients' willingness to participate in the study. exclusion criteria: patients that cant't follow up in four months after treatment and haven't willingness to continue the study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Intensity of smell. Timepoint: before intervention and four months after intervention. Method of measurement: Connecticut Chemosensory Clinical Research Center test.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Ahmad Rezaeian

Isfahan University of medical sciences, Isfahan, Iran.

dr.ahmadrezaeian@gmail.com+98 31 3625 5555

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026